MAPT and tauopathy: Over 50 MAPT mutations are linked to FTLD‐tau and may contribute to pathology through mechanisms shared with sporadic tauopathies, including by promoting tau aggregation and prion‐like activity, reducing microtubule binding and destabilizing microtubules, increasing the ratio of 4R:3R tau, or a combination of these interrelated factors.23